JPSI

Summary: Biomarker‑estimated flavan‑3‑ol intake is associated with lower blood pressure in cross‑sectional analysis in EPIC Norfolk

Ottaviani JI, Britten A, Lucarelli D, Luben R, Mulligan A, Lentjes MA, Fong R, Gray N, Grace PB, Mawson D, Tym A, Wierzbicki A, Forouhi NG, Khaw KT, Schroeter H, Kuhnle GGC; Oct. 2020

Objective:

In this study, we investigated cross-sectional associations between biomarker-estimated flavan-3-ol intake and blood pressure and other CVD risk markers, as well as longitudinal associations with CVD risk in 25,618 participants of the European Prospective Investigation into Cancer (EPIC) Norfolk cohort.

‍

PubMed link:

https://pubmed.ncbi.nlm.nih.gov/33087825/

‍

PDF summary:

View PDF